Aurobindo Pharma Ltd., Blue Star Ltd., Britannia Industries Ltd. and Delhivery Ltd. are among the top names that will announce their quarterly results on Wednesday.
Here are what analysts are expecting from these major names:
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
-
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI -
"I Am A Material Man In A Material World': Quantum Advisors' Ajit Dayal On NDTV Profit Ignite
Aurobindo Pharma
Aurobindo Pharama Ltd. is likely to clock a rise in net profit to Rs 896.9 crore and a revenue of Rs 8,150 crore for the quarter ended September, and earnings before interest, taxes, depreciation and amortisation of Rs 1,655 crore, according to a survey of analysts' estimates done by Bloomberg.
Blue Star
Blue Star Ltd. will be reporting its results for the second quarter of fiscal 2026. The company is likely to report a net profit of Rs 94.8 crore, revenue of Rs 2,414.6 crore, and an Ebitda of Rs 155.3 crore, according to estimates.
Britannia Industries
Britannia Industries Ltd. will be posting its results for the second quarter of financial year 2026. The company is estimated to report a net profit of Rs 310 crore, revenue of Rs 10,403.7 crore, according to estimates.
Delhivery
Delhivery Ltd. will be announcing its results for the second quarter of fiscal 2026. The company is likely to report a net profit of Rs 592.1 crore, revenue of Rs 4,950.6 crore, and an Ebitda of Rs 694 crore, according to estimates.
Piramal Pharma
Piramal Pharma Ltd. will be announcing its results for the second quarter of fiscal 2026. The company is likely to report a net loss of Rs 18.14 crore, revenue of Rs 211.4 crore, and an Ebitda of Rs 188.2 crore, according to estimates.
Sun Pharmaceutical Industries
Sun Pharmaceutical Industries Ltd. will be announcing its results for the second quarter of fiscal 2026. The company is likely to report a net profit of Rs 2,881.1 crore, revenue of Rs 14,244.7 crore, and an Ebitda of Rs 4,025.5 crore, according to estimates.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
